XML 81 R21.htm IDEA: XBRL DOCUMENT
v3.20.1

Earnings Per Share | 3 Months Ended
--- | ---
Mar. 28, 2020
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share:
|  | Three Months Ended
(in thousands, except per share amounts) |  | March 28, 2020 |  | March 30, 2019
Numerator: |  |  |  |
Net income as reported |  | $ | 24,644 |  |  | $ | 36,989 |
Denominator: |  |  |  |
Weighted average shares outstanding |  |  |  |
Basic |  | 24,393 |  |  | 24,717 |
Effect of dilutive securities |  | 185 |  |  | 292 |
Diluted |  | 24,578 |  |  | 25,009 |
Earnings Per Share: |  |  |  |
Basic earnings per share |  | $ | 1.01 |  |  | $ | 1.50 |
Diluted earnings per share |  | $ | 1.00 |  |  | $ | 1.48 |
Potential shares of common stock relating to stock options excluded from the earnings per share calculation because their effect would be anti-dilutive were 153,836 and 77,047 for the three months ended March 28, 2020 and March 30, 2019, respectively. Share Repurchase Program The Company’s Board of Directors authorized the repurchase of up to 1,000,000 shares of the Company’s common stock under a program for the period May 1, 2018 to April 30, 2019 ("2018 program"). On April 26, 2019, the Company's Board of Directors authorized to a program to repurchase up to 1,000,000 shares of the Company's common stock for the period May 1, 2019 to April 30, 2020 ("2019 program") to replace its previous expired 2018 program. On April 23, 2020, the Company's Board of Directors authorized a new program to repurchase up to 1,000,000 shares of the Company's common stock for the period May 1, 2020 to April 30, 2021 (the "2020 program") to replace its previous expired 2019 program. The Company does not expect to repurchase shares in the near future due to the uncertainty of the impact and duration of COVID-19. For the three months ended March 28, 2020 and March 30, 2019, the Company repurchased 175,110 and 79,916 shares of its common stock totaling $22.9 million and $13.6 million, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration